Please use this identifier to cite or link to this item:
|Title:||Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression|
|Authors:||Noto, Cristiano [UNIFESP]|
Rizzo, Lucas Bortolotto [UNIFESP]
Mansur, Rodrigo Barbachan [UNIFESP]
McIntyre, Roger S.
Brietzke, Elisa [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
|Citation:||Neuroimmunomodulation. Basel: Karger, v. 21, n. 2-3, p. 131-139, 2014.|
|Abstract:||In the last decades convergent findings from several lines of evidence has revealed a robust association between major depressive disorder (MDD) and inflammatory pathways. Despite this, the translation of these findings into new and better treatments for MDD has not occurred. the objective of this study is to comprehensively review what is already known with reasonable certainty on inflammatory pathways in MDD, to clarify some points that have been insufficiently studied and to discuss the implications of these findings for future studies targeting inflammatory pathways as a therapeutic tool for individuals with MDD. (C) 2014 S. Karger AG, Basel|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.